[English] 日本語
![](img/lk-miru.gif)
- PDB-1omn: SOLUTION STRUCTURE OF OMEGA-CONOTOXIN MVIIC, A HIGH AFFINITY OF P... -
+
Open data
-
Basic information
Entry | Database: PDB / ID: 1omn | ||||||
---|---|---|---|---|---|---|---|
Title | SOLUTION STRUCTURE OF OMEGA-CONOTOXIN MVIIC, A HIGH AFFINITY OF P-TYPE CALCIUM CHANNELS, USING 1H NMR SPECTROSCOPY AND COMPLETE RELAXATION MATRIX ANALYSIS | ||||||
![]() | OMEGA-CONOTOXIN M VII C (M SEVEN C) | ||||||
![]() | NEUROTOXIN / P-TYPE CALCIUM CHANNEL BLOCKER / CONUS VENOM / PRESYNAPTIC NEUROTOXIN / CONOTOXIN | ||||||
Function / homology | Conotoxin, omega-type, conserved site / Omega-conotoxin family signature. / host cell presynaptic membrane / ion channel inhibitor activity / calcium channel regulator activity / toxin activity / extracellular region / Omega-conotoxin MVIIC![]() | ||||||
Biological species | ![]() | ||||||
Method | SOLUTION NMR | ||||||
![]() | Farr-Jones, S. / Basus, V.J. | ||||||
![]() | ![]() Title: Solution structure of omega-conotoxin MVIIC, a high affinity ligand of P-type calcium channels, using 1H NMR spectroscopy and complete relaxation matrix analysis. Authors: Farr-Jones, S. / Miljanich, G.P. / Nadasdi, L. / Ramachandran, J. / Basus, V.J. #1: ![]() Title: A New Conus Peptide Ligand for Mammalian Presynaptic Ca2+ Channels Authors: Hillyard, D.R. / Monje, V.D. / Mintz, I.M. / Cruz, L.J. / Imperial, J.S. / Olivera, B.M. | ||||||
History |
|
-
Structure visualization
Structure viewer | Molecule: ![]() ![]() |
---|
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 99.7 KB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | 81 KB | Display | ![]() |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Summary document | ![]() | 353.6 KB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 435.3 KB | Display | |
Data in XML | ![]() | 8.5 KB | Display | |
Data in CIF | ![]() | 13.6 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Similar structure data |
---|
-
Links
-
Assembly
Deposited unit | ![]()
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 |
| |||||||||
Atom site foot note | 1: LYS 2 - GLY 3 MODEL 1 OMEGA = 148.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 2: GLY 3 - LYS 4 MODEL 1 OMEGA = 210.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 3: LYS 25 - CYS 26 MODEL 1 OMEGA = 210.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 4: CYS 1 - LYS 2 MODEL 2 OMEGA = 210.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 5: ARG 9 - LYS 10 MODEL 2 OMEGA = 210.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 6: CYS 16 - SER 17 MODEL 2 OMEGA = 210.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 7: GLY 18 - SER 19 MODEL 2 OMEGA = 210.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 8: LYS 4 - GLY 5 MODEL 3 OMEGA = 210.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 9: ARG 9 - LYS 10 MODEL 3 OMEGA = 210.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 10: MET 12 - TYR 13 MODEL 3 OMEGA = 149.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 11: CYS 16 - SER 17 MODEL 3 OMEGA = 210.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 12: GLY 18 - SER 19 MODEL 3 OMEGA = 210.74 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 13: LYS 2 - GLY 3 MODEL 4 OMEGA = 149.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 14: GLY 3 - LYS 4 MODEL 4 OMEGA = 210.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 15: LYS 25 - CYS 26 MODEL 4 OMEGA = 210.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 16: GLY 3 - LYS 4 MODEL 5 OMEGA = 210.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 17: ARG 9 - LYS 10 MODEL 5 OMEGA = 210.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 18: GLY 18 - SER 19 MODEL 5 OMEGA = 210.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 19: LYS 25 - CYS 26 MODEL 5 OMEGA = 211.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 20: LYS 2 - GLY 3 MODEL 6 OMEGA = 149.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 21: CYS 1 - LYS 2 MODEL 7 OMEGA = 210.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 22: LYS 2 - GLY 3 MODEL 7 OMEGA = 148.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 23: GLY 3 - LYS 4 MODEL 7 OMEGA = 210.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 24: ARG 9 - LYS 10 MODEL 7 OMEGA = 210.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 25: CYS 16 - SER 17 MODEL 7 OMEGA = 210.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 26: LYS 25 - CYS 26 MODEL 7 OMEGA = 211.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 27: LYS 2 - GLY 3 MODEL 8 OMEGA = 149.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 28: CYS 16 - SER 17 MODEL 8 OMEGA = 210.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 29: ARG 9 - LYS 10 MODEL 9 OMEGA = 210.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 30: CYS 16 - SER 17 MODEL 9 OMEGA = 210.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 31: CYS 1 - LYS 2 MODEL 10 OMEGA = 210.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 32: LYS 2 - GLY 3 MODEL 10 OMEGA = 148.67 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 33: GLY 3 - LYS 4 MODEL 10 OMEGA = 210.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 34: ARG 9 - LYS 10 MODEL 10 OMEGA = 210.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 35: CYS 20 - GLY 21 MODEL 10 OMEGA = 210.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 36: LYS 25 - CYS 26 MODEL 10 OMEGA = 210.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 37: LYS 2 - GLY 3 MODEL 11 OMEGA = 149.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 38: SER 17 - GLY 18 MODEL 11 OMEGA = 210.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 39: ARG 9 - LYS 10 MODEL 12 OMEGA = 210.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 40: LYS 25 - CYS 26 MODEL 12 OMEGA = 211.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 41: LYS 2 - GLY 3 MODEL 13 OMEGA = 149.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 42: GLY 3 - LYS 4 MODEL 13 OMEGA = 210.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 43: ARG 9 - LYS 10 MODEL 13 OMEGA = 210.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 44: LYS 25 - CYS 26 MODEL 13 OMEGA = 210.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 45: ARG 9 - LYS 10 MODEL 14 OMEGA = 210.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 46: ASP 14 - CYS 15 MODEL 14 OMEGA = 210.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 47: CYS 16 - SER 17 MODEL 15 OMEGA = 210.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION | |||||||||
NMR ensembles |
|
-
Components
#1: Protein/peptide | Mass: 2761.348 Da / Num. of mol.: 1 / Source method: isolated from a natural source / Source: (natural) ![]() |
---|
-Experimental details
-Experiment
Experiment | Method: SOLUTION NMR |
---|
-
Sample preparation
Crystal grow | *PLUS Method: other |
---|
-
Processing
Software | Name: ![]() |
---|---|
NMR software | Name: ![]() Developer: PEARLMAN,CASE,CALDWELL,SEIBEL,SINGH,WEINER,KOLLMAN Classification: refinement |
NMR ensemble | Conformers submitted total number: 15 |